MRI retinovascular studies in humans: Research in patients with diabetes

NMR in Biomedicine

Volumn 21, Issue 9, 2008, Pages 1003-1012

  Trick, Gary L ^a,b   Edwards, Paul A ^a   Desai, Uday ^a   Morton, Paula E ^b   Latif, Zahid ^b   Berkowitz, Bruce A ^b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Human; Macular edema; MRI; Oxygenation; Retina; Retinopathy

Indexed keywords

ANIMALS; APPLICATIONS; DYNAMIC RESPONSE; IMAGE ENHANCEMENT; OXYGENATION; OXYGENATORS; SIGNAL SYSTEMS; SUGAR (SUCROSE);

DIABETES; HUMAN; MACULAR EDEMA; MRI; RETINA; RETINOPATHY;

EYE PROTECTION;

GADOLINIUM PENTETATE;

BLOOD RETINA BARRIER; CONTRAST ENHANCEMENT; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DIAGNOSTIC VALUE; HUMAN; HYPEROXIA; INSULIN DEPENDENT DIABETES MELLITUS; LOW LEVEL LASER THERAPY; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA BLOOD VESSEL; REVIEW; TISSUE OXYGENATION;

ANIMALS; BLOOD-RETINAL BARRIER; DIABETES MELLITUS; DIABETIC RETINOPATHY; HUMANS; MAGNETIC RESONANCE IMAGING; OXYGEN; RETINA;

ANIMALIA;

EID: 57149131694     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1314     Document Type: Review

References (45)

1. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, 3rd, Klein R. American Diabetes Association. Retinopathy in diabetes. Diabetes Care 2004; 27: S84-S87.
2. National Diabetes Information Clearinghouse. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm#7
3. Facts and Figures, Diabetes Programme,. World Health Organization. http://www.who.int/diabetes/facts/work_figures/en/
4. Klein R, Klein BEK, Moss SE, Cruickshanks K. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XV: the long-term incidence of macular edema. Ophthalmology 1995; 102: 7-16.
5. Ferris FL III, Patz A. Macular edema: a complication of diabetic retinopathy. Surv Ophthalmol 1984; 28(Suppl.): 452-461.
6. Comer GM, Ciulla TA. Pharmacotherapy for diabetic retinopathy. Curr Opin Ophthalmol 2004; 15(6): 508-518.
7. Emerson MV, Lauer AK. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema. BioDrugs 2007; 21(4): 245-257.
8. Trick GL, Liggett J, Levy J, Adamsons I, Edwards P, Desai U, Tofts PS, Berkowitz BA. Dynamic contrast enhanced MRI in patients with diabetic macular edema: initial results. Exp Eye Res 2005; 81(1): 97-102.
9. 2 mapping. Invest Ophthalmol Vis Sci 1996; 37(10): 2089-2098.
10. Berkowitz BA, Tofts PS, Sen HA, et al. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI. Invest Ophthalmol Vis Sci 1992; 33(13): 3500-3506.
11. Berkowitz BA, Wilson CA, Tofts PS, Peshock RM. Effect of vitreous fluidity on the measurement of blood-retinal barrier permeability using contrast-enhanced. MRI Magn Reson Med 1994; 31: 61-66.
12. Tofts PS, Berkowitz BA. Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods. Magn Reson imaging 1994; 12: 81-91
13. Berkowitz BA, Roberts R, Luan H, Peysakhov J, Mao X, Thomas KA. Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats. Invest Ophthalmol Vis Sci 2004; 45(7): 2391-2398.
14. Sander B, Larsen M, Moldow B, Lund-Andersen H. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. Invest Ophthalmol Vis Sci 2001; 42: 433-438.
15. Sander B, Larsen M, Engler C, Moldow B, Lund-Andersen H. Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier. Br J Ophthalmol 2002; 86: 1139-1142.
16. Sander B, Larsen M, Engler C, Strom C, Moldow B, Larsen N, et al. Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy. Br J Ophthalmol 2002; 86: 316-320.
17. Trick GL, Edwards P, Desai U, Berkowitz BA. Early supernormal retinal oxygenatien response in patients with diabetes. Invest Ophthalmol Vis Sci 2006; 47(4): 1612-1619.
18. Yu DY, Cringle SJ. Retinal degeneration and local oxygen metabolism. Exp Eye Res 2005; 80(6): 745-751.
19. Wangsa-Wirawan ND, Linsenmeier RA. Retinal oxygen: fundamental and clinical aspects. Arch Ophthalmol 2003; 121: 547-557.
20. Yu D-Y, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retina Eye Res 2001; 20: 175-208.
21. Linsenmeier R, Padnick-Silver L. Metabolic dependence of photoreceptors on the choroid in the normal and detached retina. Invest Ophthalmol Vis Sci 2000; 41: 2678-2683.
22. Harris A, Ciulla TA, Chung HS, Martin B. Regulation of retinal and optic nerve blood flow. Arch Ophthalmol 1998; 116(11): 1491-1495.
23. Yu DY, Cringle SJ, Su EN. Intraretinal oxygen distribution in the monkey retina and the response to systemic hyperoxia. Invest Ophthalmol Vis Sci 2005; 46(12): 4728-4733.
24. Shonat RD. Oxygen delivery to the retina and related visual pathology. Brief review. Adv Exp Med Biol 2003; 510: 249-254.
25. Ikeda E. Cellular response to tissue hypoxia and its involvement in disease progression. Pathol Int 2005; 55(10): 603-610.
26. Weinberger B, Laskin DL, Heck DE, Laskin JD. Oxygen toxicity in premature infants. Toxicol Appl Pharmacol 2002; 181(1): 60-67.
27. Winkler BS, Boulton ME, Gottsch JD, Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vis 1999; 5: 32.
28. Shen J, Yang X, Dong A, Petters RM, Peng YW, Wong F, Campochiaro PA. Oxidative damage is a potential cause of cone cell death in retinitis pigmentosa. J Cell Physiol 2005; 203(3): 457-464.
29. Nelson DA, Krupsky S, Pollack A, Aloni E, Belkin M, Vanzetta I, Rosner M, Grinvald A. Special report: noninvasive multiparameter functional optical imaging of the eye. Ophthalmic Surg Lasers Imaging 2005; 36(1): 57-66.
30. Hammer M, Thamm E, Schweitzer D. A simple algorithm for in vivo ocular fundus oximetry compensating for non-haemoglobin absorption and scattering. Phys Med Biol 2002; 47(17): N233.
31. 2) in the human ocular fundus measured by reflectance oximetry: preliminary data in retinal veins. Klin Monatsbl Augenheilkd 2002; 219(4): 289-291.
32. Beiran I, Reissman P, Scharf J, Nahum Z, Miller B. Hyperbaric oxygenation combined with nifedipine treatment for recent-onset retinal artery occlusion. Eur J Ophthalmol 1993; 3: 89-94.
33. Gloster J. Fundus oximetry. Exp Eye Res 1967; 6(3): 187-212.
34. Beach JM, Schwenzer KJ, Srinivas S, Kim D, Tiedeman JS. Oximetry of retinal vessels by dual-wavelength imaging: calibration and influence of pigmentation. J Appl Physiol 1999; 86(2): 748-758.
35. Harris A, Dinn RB, Kagemann L, Rechtman E. A review of methods for human retinal oximetry. Ophthalmic Surg Lasers Imaging 2003; 34(2): 152-164.
36. Wilson CA, Berkowitz BA, McCuen BW 2nd, Charles HC. Measurement of preretinal oxygen tension in the vitrectomized human eye using fluorine-19 magnetic resonance spectroscopy. Arch Ophthalmol 1992; 110(8): 1098-1100.
37. Trick GL, Berkowitz BA. Retinal oxygenation response and retinopathy. Prog Retin Eye Res 2004; 24(2): 259-274.
38. Linsenmeier RA, Goldstick TK, Blum RS, Enroth-Cugell C. Estimation of retinal oxygen transients from measurements made in the vitreous humor. Exp Eye Res 1981; 32(4): 369-379.
39. Berkowitz BA, McDonald C, Ito Y, Tofts PS, Latif Z, Gross J. Measuring the human retinal oxygenation response to a hyperoxic challenge using MRI: eliminating blinking artifacts and demonstrating proof of concept. Magn Reson Med 2001; 46: 412-416.
40. Roberts R, Luan H, Berkowitz BA. alpha-Lipoic acid corrects late-phase supernormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 2006; 47(9): 4077-4082.
41. Berkowitz BA, Roberts R, Luan H, Peysakhov J, Knoerzer DL, Connor JR, Hohman TC. Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci 2005; 46(8): 2954-2960.
42. Berkowitz BA, Luan H, Gupta RR, Pacheco D, Seidner A, Roberts R, Liggett J, Knoerzer DL, Connor JR. Du Y, Kern TS, Ito Y. Regulation of the early subnormal retinal oxygenation response in experimental diabetes by inducible nitric oxide synthase. Diabetes 2004; 53(1): 173-178.
43. Berkowitz BA, Kowluru RA, Frank RN, Kern TS, Hohman TC, Prakash M. Subnormal retinal oxygenation response precedes diabetic-like retinopathy. Invest Ophthalmol Vis Sci 1999; 40(9): 2100-2105.
44. Luan H, Leitges M, Gupta RR, Pacheco D, Seidner A, Liggett J, Ito Y, Kowluru R. Berkowitz BA. Effect of PKCbeta on retinal oxygenation response in experimental diabetes. Invest Ophthalmol Vis Sci 2004; 45(3): 937-942.
45. Bearse MA Jr, Adams AJ, Han Y, Schneck ME, Ng J, Bronson-Castain K, Barez S. A multifocal electroretinogram model predicting the development of the diabetic retinopathy. Prog Retin Eye Res 2006; 25: 425-448.